1. Vitiligo‐like depigmentation affecting sun‐exposed areas caused by palbociclib
   Nuria Barrientos Pérez et al, 2024, Photodermatology, Photoimmunology & Photomedicine CrossRef
2. Emerging Skin Toxicities in Patients with Breast Cancer Treated with New Cyclin-Dependent Kinase 4/6 Inhibitors: A Systematic Review
   Martina Silvestri et al, 2021, Drug Safety CrossRef
3. Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors
   Pietro Sollena et al, 2021, Breast Cancer Research and Treatment CrossRef
4. Vitiligo-Like Lesions in a Patient with Metastatic Breast Cancer Treated with Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor: A Case Report and Literature Review
   Baha' Sharaf et al, 2022, Clinical, Cosmetic and Investigational Dermatology CrossRef
5. Ufl1 deficiency causes skin pigmentation by up-regulation of Endothelin-1
   Ke Wang et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
6. Emerging Roles of Post-Translational Modifications in Skin Diseases: Current Knowledge, Challenges and Future Perspectives
   Luting Yang et al, 2022, Journal of Inflammation Research CrossRef
7. Vitiligo-like lesions induced by cyclin-dependent kinase 4/6 inhibitor Palbociclib: a case report and literature review
   Shan Gao et al, 2023, Pathology and Oncology Research CrossRef